RxDoctor Payments Data

Marcina Bailey, APRN

Family · Middlesboro, KYNPI 1548673155

Payments from drug & device makers

$753in general payments, 2019–2025

Across 40 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$278
  • GSK$154
  • Novo Nordisk$77
  • Johnson & Johnson$65
  • Vertex$55
  • Alkermes, Inc.$43
  • plus $82 from 4 others

What the payments were for

  • Food & beverage$753100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$753 in reported general payments places this provider in the 55th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$48,469
Medicare patients
151
Services billed
671

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide53$50,785
MounjaroTirzepatide30$32,602
LinzessLinaclotide51$28,658
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$20,137
JardianceEmpagliflozin19$17,259
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen875$17,047
EliquisApixaban13$15,871
Breo ElliptaFluticasone/Vilanterol38$14,822
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr29$13,311
TrulicityDulaglutide13$13,285
Combivent RespimatIpratropium/Albuterol Sulfate23$11,232
XareltoRivaroxaban11$10,656
Repatha SureclickEvolocumab12$10,000
Tresiba Flextouch U-100Insulin Degludec13$8,576
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$8,163

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$77$50,78553 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$154$48,27093 claims
Johnson & JohnsonXarelto$65$10,65611 claims
AstraZenecaBreztri Aerosphere$278$8,16313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,374 family providers in Kentucky.

Other family in Middlesboro

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →